The upgrades will allow for Avista to expand its analytical chemistry suite along with its compendial and raw material testing capabilities.
A spokesperson from Avista told us that, by being able to broaden the testing capabilities, it positions the Agawam site as a “preferred provider for microbiological and analytical testing of pharmaceuticals and medical devices.”
Additionally, the contract development and manufacturing organization (CDMO) will open an office in the Boston metro area. This office will be an extension of the company’s microbiology, analytical and cleanroom service options that are available at its Agawam facility.
The upgrades will include a new 950-square-foot lab space. While not a building upgrade, the company will now offer a courier service to ensure that time-sensitive sample pickups from client facilities in the area are delivered swiftly for testing.
The expansion and upgrades to the facilities will allow an undisclosed number of more employees to join the company.
Avista was unable to share financial information regarding this expansion but told us that “this [investment] is a continuation of Avista’s overall capacity expansion across all locations.”